American Well Corp. Class AAMWL

13F holders, Q1 2024 (March 31)
1holders
$0.81avg. 13F price*

At the end of Q1 2024, 1 institutions reported holding American Well Corp. Class A (AMWL) in their 13F filings. The largest holder was Takeda Pharmaceutical Co. Ltd. ($1.3M).

Company
American Well Corp. Class A
CUSIP
03044L204
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q1 2024: 1Q1 2024Q2 2024: 8Q2 2024Q3 2024: 64Q3 2024Q4 2024: 67Q4 2024Q1 2025: 64Q1 2025Q2 2025: 59Q2 2025Q3 2025: 59Q3 2025Q4 2025: 57Q4 2025Q1 2026: 55Q1 2026Q2 2026: 55Q2 2026

Total Exit/New Position Q1 2024

No earlier quarter to compare with.

Ownership 1 holders

Takeda Pharmaceutical Co. Ltd. 0.44% No change 1,554,669 $1.3M

"% of holder's portfolio" is AMWL's weight in each manager's 13F, not the share of American Well Corp. Class A the manager owns.